Cencora Inc. logo

Cencora Inc. (COR)

Market Closed
24 Jun, 20:00
NYSE NYSE
$
294. 13
+1
+0.34%
$
57.52B Market Cap
- P/E Ratio
2.2% Div Yield
1,532,485 Volume
- Eps
$ 293.13
Previous Close
Day Range
287.43 294.43
Year Range
218.65 309.35
Want to track COR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 35 days

Summary

COR closed today higher at $294.13, an increase of 0.34% from yesterday's close, completing a monthly increase of 1.52% or $4.41. Over the past 12 months, COR stock gained 30.22%.
COR pays dividends to its shareholders, with the most recent payment made on Jun 02, 2025. The next estimated payment will be in In 2 months on Sep 02, 2025 for a total of $0.55.
The last earnings report, released on Apr 29, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.12%, based on the last three reports. The next scheduled earnings report is due on Jul 29, 2025.
Cencora Inc. has completed 4 stock splits, with the recent split occurring on Jun 16, 2009.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

COR Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Camino Announces High-Grade Channel Results of 7 Meters @ 4.3% Copper, 25.5 ppm Silver and 18 meters @ 1.57 % Copper and 11.35 ppm Silver at Los Chapitos in Peru

Camino Announces High-Grade Channel Results of 7 Meters @ 4.3% Copper, 25.5 ppm Silver and 18 meters @ 1.57 % Copper and 11.35 ppm Silver at Los Chapitos in Peru

VANCOUVER, BC / ACCESS Newswire / June 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce high‐grade copper channel results from the Katty prospect located in the Diva Trend, one of several prospective targets at the Company's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru. A total of 12 excavated channels were completed at the prospect and all channels contained significant high-grade intercepts of copper with associated silver (Table 1).

Accessnewswire | 1 week ago
Nittetsu Mining Provides $1.5 Million Fifth Earn-in Payment for Camino's Los Chapitos Project

Nittetsu Mining Provides $1.5 Million Fifth Earn-in Payment for Camino's Los Chapitos Project

VANCOUVER, BC / ACCESS Newswire / June 5, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the receipt of CAD$1.5 million from exploration partner Nittetsu Mining CO., Ltd. ("Nittetsu") to fully fund the upcoming exploration and drilling campaign at Camino's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru.

Accessnewswire | 2 weeks ago
Here's Why You Should Add Cencora Stock to Your Portfolio Now

Here's Why You Should Add Cencora Stock to Your Portfolio Now

COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Zacks | 3 weeks ago

Cencora Inc. (COR) FAQ

What is the stock price today?

The current price is $294.13.

On which exchange is it traded?

Cencora Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is COR.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 57.52B.

When is the next earnings date?

The next earnings report will release on Jul 29, 2025.

Has Cencora Inc. ever had a stock split?

Cencora Inc. had 4 splits and the recent split was on Jun 16, 2009.

Cencora Inc. Profile

Medical - Distribution Industry
Healthcare Sector
Dr. Robert P. Mauch Ph.D., PharmD CEO
NYSE Exchange
03090BBJ8 Cusip
US Country
42,000 Employees
14 Feb 2025 Last Dividend
16 Jun 2009 Last Split
- IPO Date

Overview

Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.

Products and Services

U.S. Healthcare Solutions:

  • Distribution Services: Includes distributing pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide range of healthcare providers such as acute care hospitals, retail pharmacies, and mail order pharmacies.
  • Pharmacy Management and Consulting Services: Offers pharmacy management, staffing, supply management software, and consulting services to retail and institutional healthcare providers.
  • Packaging Solutions: Provides innovative packaging solutions to institutional and retail healthcare providers to ensure safety and efficiency in medication dispensing.
  • Support Services for Clinical Trials: Offers clinical trial support, product post-approval, and commercialization support services, coupled with data analytics and research services for biotechnology and pharmaceutical manufacturers.
  • Veterinary Products and Services: Distributes pharmaceuticals, vaccines, and other products for companion and production animals, along with providing sales force services to manufacturers.
  • Specialty Products and Services: Involves the distribution of plasma and other blood products, injectable pharmaceuticals, vaccines, and offers services to physicians specializing in various disease states, including oncology, hospitals, and dialysis clinics.

International Healthcare Solutions:

  • Pharmaceutical Wholesale and Related Service: Offers international pharmaceutical wholesale, distribution, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe.
  • Global Commercialization Services: Provides global commercialization services to enhance the reach and impact of pharmaceutical products across international markets.
  • Specialty Transportation and Logistics: Delivers specialty transportation and logistics services tailored for the biopharmaceutical industry, focusing on the secure and efficient delivery of pharmaceutical products.

Contact Information

Address: 1 West First Avenue
Phone: 610 727 7000